Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Conventional methods for detection of Neisseria gonorrhoeae causing gonorrhea have been gradually replaced by nucleic
acid amplification tests (NAATs). However, all these NAATs have inherent disadvantages of requiring a high precision
instrument for amplification or an elaborate complicated method for detection of amplified products. Thus, for settings with
minimal facilities, there is a need for a simple reliable test that would permit the screening of N. gonorrhoeae. Therefore, in
this study we develop and compare LAMP with PCR for detection of N. gonorrhoeae. LAMP has been reported to amplify
DNA without any special requirement with high specificity, efficiency and rapidity under isothermal conditions. LAMP assay
and PCR were developed with self-designed primers for opa gene separately. LAMP and PCR were standardized by using N.
gonorrhoeae (ATCC 49226). Serial dilutions of DNA extracted from N. gonorrhoeae (ATCC 49226) were used to determine
the sensitivity of the assay. Specificity was checked using N. gonorrhoeae (ATCC 49226, clinical isolates n=41), N. sicca (ATCC
29193, clinical isolates n=6), N. meningitidis (ATCC 13078, clinical isolates n=2), Escherichia coli (ATCC 25922), Staphylococcus
aureus (ATCC 25923), Pseudomonas aeruginosa (ATCC 27853), Streptococcus pyogenes and Chlamydia trachomatis. LAMP
was highly specific for N. gonorrhoeae showing no cross-reaction. LAMP showed amplification within 30 minutes. Detection
limit of LAMP and PCR were 4 fg and 4 pg respectively. LAMP showed concordance (94.4%) with PCR in clinical samples. This
LAMP assay offers a highly sensitive and specific assay for the detection and confirmation of N. gonorrhoeae, thereby saving
time and cost.